Introduction
Caspase-7 is an executioner caspase in the caspase family of cysteine proteases that plays a central role in programmed cell death (apoptosis). It is one of the key effector caspases that executes the apoptotic program by cleaving a broad range of cellular substrates. In neurodegenerative diseases like Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS), caspase-7 activation contributes to neuronal loss through both apoptosis and non-apoptotic functions. Understanding caspase-7’s role in neurodegeneration is crucial for developing therapeutic strategies targeting cell death pathways.
Protein Infobox
Structure
Caspase-7 is synthesized as a zymogen (pro-caspase-7) that requires activation:
-
Pro-domain: Contains a short N-terminal prodomain (~23 amino acids)
-
Large subunit (p20): Contains the catalytic cysteine residue
-
Small subunit (p12): Completes the active site formation
-
Active form: The heterotetrameric active caspase-7 consists of two p20/p12 heterodimers
-
Catalytic dyad: His237 and Cys277 form the catalytic dyad essential for protease activity
-
Substrate-binding pocket: Recognizes the DEVD tetrapeptide sequence (caspase-7 preferred cleavage site)
Crystal structures of active caspase-7 (PDB: 1F1J, 3KAI) have revealed the dimeric architecture and substrate-binding mechanisms.
Normal Function
In healthy cells, caspase-7 participates in several important processes:
-
Apoptosis execution: Caspase-7 is activated by initiator caspases (caspase-8, caspase-9) via proteolytic cleavage
-
Substrate cleavage: Cleaves structural proteins (lamins, gelsolin), repair enzymes (PARP), and signaling molecules
-
Cell disassembly: Facilitates cellular dismantling during programmed cell death
-
Development: Essential for normal embryonic development (caspase-7 knockout mice are viable but show defects)
-
Immune regulation: Participates in immune cell homeostasis and cytokine processing
Role in Neurodegeneration
Alzheimer’s Disease
Caspase-7 is activated in AD brains and contributes to neuronal death:
-
Amyloid-beta toxicity: Aβ exposure triggers caspase-7 activation in neurons
-
Tau cleavage: Caspase-7 cleaves tau protein, generating toxic fragments that may propagate pathology
-
Synaptic loss: Caspase-7 activation leads to synaptic protein degradation
-
PARP cleavage: Excessive caspase-7 activation causes PARP cleavage, leading to energy depletion and cell death
Parkinson’s Disease
In PD, caspase-7 mediates dopaminergic neuron loss:
-
Mitochondrial dysfunction: Mitochondrial toxins activate caspase-7
-
Alpha-synuclein toxicity: Caspase-7 is activated by alpha-synuclein aggregates
-
Neuroinflammation: Glial activation triggers caspase-7 in neighboring neurons
Amyotrophic Lateral Sclerosis
Caspase-7 contributes to motor neuron degeneration in ALS:
-
Mutant SOD1 toxicity: Caspase-7 is activated in ALS models with mutant SOD1
-
Excitotoxicity: Glutamate excitotoxicity triggers caspase-7 activation
-
Axonal degeneration: Caspase-7 mediates axonal breakdown
Stroke and Traumatic Brain Injury
Caspase-7 activation following ischemia or trauma contributes to secondary neuronal damage.
Therapeutic Targeting
Caspase-7 is a therapeutic target for neurodegenerative diseases:
-
Caspase inhibitors: Pan-caspase and caspase-7-selective inhibitors have been developed
-
Neuroprotective strategies: Targeting upstream activators to prevent caspase-7 activation
-
Peptide-based inhibitors: DEVD-based peptides can block caspase-7 activity
-
Challenges: Broad caspase inhibition affects vital cellular functions
Key Publications
-
Miller et al., Caspase-7 cleavage in Alzheimer’s disease (2000)
-
Burguillos et al., Caspase signalling controls microglia activation (2011)
-
Gao et al., Caspase-7 activation in Parkinson’s disease (2005)
See Also
-
Caspase-3 - Related executioner caspase
-
Caspase-9 - Initiator caspase in intrinsic apoptosis
-
Apoptosis Pathways - Cellular apoptosis mechanisms
-
Alzheimer’s Disease - AD overview
-
Parkinson’s Disease - PD overview
External Links
References
- Role of caspase-7 in Alzheimer's disease (2005)
- Caspase signalling controls microglia activation and neurotoxicity (2011)
- Caspase-7 activation in dopaminergic neurons in Parkinson's disease (2005)
- Abraham & Shah, Caspase-3 and Caspase-7 in neurodegeneration (2002)
- Caspase-7 mediates tau cleavage in Alzheimer's disease (2019)
- Caspase-7 in amyotrophic lateral sclerosis (2012)
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.